Orestes Santos Morales

Center of Molecular Immunology (Cuba) — CU

Medicine · Health Sciences

6h-index101citations13works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(6), Lung Cancer Research Studies(5), Cancer Immunotherapy and Biomarkers(4), Colorectal Cancer Treatments and Studies(2), Cancer Research and Treatments(2)

Publications13 total

A Phase I Study of Nimotuzumab With Nivolumab in Advanced Non-small Cell Lung Cancer and Head and Neck Squamous Cell Cancer
Cureus·2025Open Access
Real-World Effectiveness of Racotumomab as Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
Vaccines·2025Open Access
EP.12A.35 A Phase I Open-label Study Ofnimotuzumab with Nivolumab in Advanced Non-Small Cell Lung Cancer or Head and Neck Squamous Cell Cancer
Journal of Thoracic Oncology·2024· 1 citedOpen Access
PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients
Vaccines·2024Open Access
Abstract CT126: A Phase 0 Study of EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Cancer Research·2024· 2 cited
Safety and effectiveness of CIMAvax-EGF administered in community polyclinics
Frontiers in Oncology·2024· 10 citedOpen Access
Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2023· 7 cited
Immune Deprivation of Growth Factors as Cancer Therapy
2023
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
Frontiers in Oncology·2022· 11 citedOpen Access
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study
Movement Disorders·2022· 14 cited
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer
Frontiers in Oncology·2021· 16 citedOpen Access
High Levels of Serum EGF Concentration Predict Response to Cimavax-EGF Treatment in Advanced NSCLC
Journal of Cancer Science and Clinical Therapeutics·2020· 1 citedOpen Access
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study
BMC Neurology·2017· 39 citedOpen Access

Frequent Co-authors

Tania Crombet(10), Kalet León(7), Grace K. Dy(5), Danay Saavedra(5), Mary E. Reid(4), Patricia Lorenzo Luaces(4), Rachel Frascati(4), Adrienne Groman(3), Christos Fountzilas(3), Idrian García‐García(2), Daniel Amaro‐González(2), Julio Rodríguez(2), Agustín Lage Dávila(2), Carmen Viada González(2), Jason B. Muhitch(2), Askia Dozier(2), Circe Mesa(2), Igor Puzanov(2), Kristopher Attwood(2), Alan D. Hutson(2)